Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

BACKGROUND/AIMS: Tenofovir disoproxil fumarate (TDF) exhibits similar antiviral efficacy against treatment-naïve and lamivudine (LAM)-resistant chronic hepatitis B (CHB). However, there are few clinical reports on the antiviral effects of TDF–LAM combination therapy compared to TDF monotherapy in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Chan Ho, Jung, Seok Won, Shin, Jung Woo, Bae, Mi Ae, Lee, Yoon Im, Park, Yong Tae, Chung, Hwa Sik, Park, Neung Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825170/
https://www.ncbi.nlm.nih.gov/pubmed/27044766
http://dx.doi.org/10.3350/cmh.2016.22.1.152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825170/
https://www.ncbi.nlm.nih.gov/pubmed/27044766
http://dx.doi.org/10.3350/cmh.2016.22.1.152

Ejemplares similares